电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

EIF4E 抗体

Cited in 3+ publications. The 兔 多克隆 anti-EIF4E antibody (ABIN966057) specifically detects EIF4E in IHC. The antibody is reactive with 人, 大鼠 和 小鼠 samples.
产品编号 ABIN966057
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for EIF4E 抗体 (ABIN966057)

抗原

See all EIF4E 抗体
EIF4E (Eukaryotic Translation Initiation Factor 4E (EIF4E))

适用

  • 146
  • 90
  • 78
  • 20
  • 5
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
人, 大鼠, 小鼠

宿主

  • 131
  • 15
  • 2

克隆类型

  • 100
  • 48
多克隆

标记

  • 62
  • 11
  • 8
  • 6
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
This EIF4E antibody is un-conjugated

应用范围

  • 127
  • 69
  • 51
  • 39
  • 34
  • 33
  • 32
  • 27
  • 26
  • 16
  • 7
  • 6
  • 2
Immunohistochemistry (IHC)
  • 特异性

    ElF4E (Ab-209) antibody detects endogenous levels of total elF4E protein.

    纯化方法

    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

    免疫原

    The antiserum was produced against synthesized non-phosphopeptide derived from human elF4E around the phosphorylation site of serine 209 (S-G-SP-T-T).
  • 应用备注

    WB: 1:500~1:1000
    IHC: 1:50~1:100.

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    100ug/100ul.

    缓冲液

    Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 50% glycerol

    储存液

    Sodium azide

    注意事项

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    -20 °C
  • Gu, Li, Zhao, Fang, Bu, Frazer, Zhao: "tRNASer(CGA) differentially regulates expression of wild-type and codon-modified papillomavirus L1 genes." in: Nucleic acids research, Vol. 32, Issue 15, pp. 4448-61, (2004) (PubMed).

    Li, McDonald, Nassar, De Benedetti: "Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression." in: Annals of surgery, Vol. 227, Issue 5, pp. 756-6l; discussion 761-3, (1998) (PubMed).

    Ohlmann, Rau, Pain, Morley: "The C-terminal domain of eukaryotic protein synthesis initiation factor (eIF) 4G is sufficient to support cap-independent translation in the absence of eIF4E." in: The EMBO journal, Vol. 15, Issue 6, pp. 1371-82, (1996) (PubMed).

  • 抗原

    EIF4E (Eukaryotic Translation Initiation Factor 4E (EIF4E))

    途径

    BCR Signaling
You are here: